Apoptosis induction by an analog of curcumin (BDMC-A) in human laryngeal carcinoma cells through intrinsic and extrinsic pathways

Cellular Oncology

Volumn 37, Issue 6, 2014, Pages 439-454

  Mohankumar, Kumaravel ^a   Pajaniradje, Sankar ^a   Sridharan, Subhashree ^a   Singh, Vivek Kumar ^a   Ronsard, Larance ^b   Banerjea, Akhil C ^b   Selvanesan, Benson Chellakkan ^c   Coumar, Mohane Selvaraj ^a   Periyasamy, Latha ^a   Rajagopalan, Rukkumani ^a  

^a PONDICHERRY UNIVERSITY   (India)

^b NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^c UNIVERSITY OF MADRAS   (India)

Author keywords

Apoptosis; BDMC A; EGFR docking; Hep 2; RT PCR; Western blotting

Indexed keywords

BIS(4-HYDROXYCINNAMOYL)METHANE; CURCUMIN; PROTEIN BAX;

ANALOGS AND DERIVATIVES; APOPTOSIS; CELL PROLIFERATION; DRUG EFFECTS; HUMAN; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL LINE, TUMOR; CELL PROLIFERATION; CURCUMIN; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84914670245     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-014-0207-3     Document Type: Article

References (55)

1. S. Ghosh, A. Ghosh, G.P. Maiti, N. Alam, A. Roy, B. Roy, S. Roychoudhury, C.K. Panda, Alterations of 3p21.31 tumor suppressor genes in head and neck squamous cell carcinoma: correlation with progression and prognosis. Int. J. Cancer 123, 2594–2604 (2008)
2. C. Salazar, R. Nagadia, P. Pandit, J. Cooper-White, N. Banerjee, N. Dimitrova, W.B. Coman, C. Punyadeera, A novel saliva-based microRNA biomarker panel to detect head and neck cancers. Cell. Oncol. 37, 331–338 (2014)
3. T. Nakaoka, A. Ota, T. Ono, S. Karnan, H. Konishi, A. Furuhashi, Y. Ohmura, Y. Yamada, Y. Hosokawa, Y. Kazaoka, Combined arsenic trioxide-cisplatin treatment enhances apoptosis in oral squamous cell carcinoma cells. Cell. Oncol. 37, 119–129 (2014)
4. D. Weiss, C. Stockmann, K. Schrödter, C. Rudack, Protein expression and promoter methylation of the candidate biomarker TCF21 in head and neck squamous cell carcinoma. Cell. Oncol. 36, 213–224 (2013)
5. B.B. Aggarwal, C. Sundaram, N. Malani, H. Ichikawa, Curcumin: the Indian solid gold. Adv. Exp. Med. Biol. 595, 1–75 (2007)
6. S. Shishodia, M.M. Chaturvedi, B.B. Aggarwal, Role of curcumin in cancer therapy. Curr. Probl. Cancer 31, 243–305 (2007)
7. N. Chakravarti, J.N. Myers, B.B. Aggarwal, Targeting constitutive and interleukin-6-inducible signal transducers and activators of transcription 3 pathway in head and neck squamous cell carcinoma cells by curcumin (diferuloylmethane). Int. J. Cancer 119, 1268–1275 (2006)
8. A. Chen, J. Xu, A.C. Johnson, Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1. Oncogene 25, 278–287 (2006)
9. S. Prakobwong, J. Khoontawad, P. Yongvanit, C. Pairojkul, Y. Hiraku, P. Sithithaworn, P. Pinlaor, B.B. Aggarwal, S. Pinlaor, Curcumin decreases cholangiocarcinogenesis in hamsters by suppressing inflammation-mediated molecular events related to multistep carcinogenesis. Int. J. Cancer 129, 88–100 (2011)
10. P. Anand, C. Sundaram, S. Jhurani, A.B. Kunnumakkara, B.B. Aggarwal, Curcumin and cancer: an “old-age” disease with an “age-old” solution. Cancer Lett. 267, 133–164 (2008)
11. J.M. Davis, E.A. Murphy, M.D. Carmichael, M.R. Zielinski, C.M. Groschwitz, A.S. Brown, J.D. Gangemi, A. Ghaffar, E.P. Mayer, Curcumin effects on inflammation and performance recovery following eccentric exercise-induced muscle damage. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292, 2168–2173 (2007)
12. B.B. Aggarwal, A. Kumar, A.C. Bharti, Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 23, 363–398 (2003)
13. J. Nautiyal, S. Banerjee, S.S. Kanwar, Y. Yu, B.B. Patel, F.H. Sarkar, A.P. Majumdar, Curcumin enhances dasatinib-induced inhibition of growth and transformation of colon cancer cells. Int. J. Cancer 128, 951–961 (2011)
14. R.J. Anto, G. Kuttan, K.V.D. Babu, K.V. Rajasekharan, R. Kuttan, Anti-tumour and free radical scavenging activity of synthetic curcuminoids. Inter. J. Pharm. 131, 1–7 (1996)
15. R.J. Anto, J. George, K.V. Babu, K.N. Rajasekharan, R. Kuttan, Antimutagenic and anticarcinogenic activity of natural and synthetic curcuminoid. Mutat. Res. 370, 127–131 (1996)
16. R. Rukkumani, K. Aruna, P.S. Varma, K.N. Rajasekaran, V.P. Menon, Comparative effects of curcumin and an analog of curcumin on alcohol and PUFA induced oxidative stress. J. Pharm. Pharm. Sci. 7, 274–283 (2004)
17. R. Rukkumani, K. Aruna, P.S. Varma, P. Viswanathan, K.N. Rajasekaran, V.P. Menon, Protective role of a novel curcuminoid on alcohol and PUFA-induced hyperlipidemia. Toxicol. Mech. Methods 15, 227–234 (2005)
18. R. Rajagopalan, S. Sridharan, V.P. Menon, Hepatoprotective role of bis-demethoxy curcumin analog on the expression of matrix metalloproteinase induced by alcohol and polyunsaturated fatty acid in rats. Toxicol. Mech. Methods 20, 252–259 (2010)
19. T. Devasena, K.N. Rajasekaran, V.P. Menon, Bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione (a curcumin analog) ameliorates DMH-induced hepatic oxidative stress during colon carcinogenesis. Pharmacol. Res. 46, 39–45 (2002)
20. M. Kumaravel, P. Sankar, P. Latha, C.S. Benson, R. Rukkumani, Antiproliferative effects of an analog of curcumin in Hep-2 cells: a comparative study with curcumin. Nat. Prod. Commun. 8, 183–186 (2013)
21. K.Y. Chang, S.Y. Tsai, S.H. Chen, H.H. Tsou, C.J. Yen, K.J. Liu, H.L. Fang, H.C. Wu, B.F. Chuang, S.W. Chou, C.K. Tang, S.Y. Liu, P.J. Lu, C.Y. Yen, J.Y. Chang, Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance. J. Biomed. Sci. 20, 43 (2013)
22. S. Haupt, M. Berger, Z. Goldberg, Y. Haupt, Apoptosis - the p53 network. J. Cell Sci. 116, 4077–4085 (2003)
23. G. Sa, T. Das, Anti cancer effects of curcumin: cycle of life and death. Cell Div. 3, 14 (2008)
24. C. Gajate, F. Mollinedo, Cytoskeleton-mediated death receptor and ligand concentration in lipid rafts forms apoptosis-promoting clusters in cancer chemotherapy. J. Biol. Chem. 280, 11641–11647 (2005)
25. H.F. Lu, K.C. Lai, S.C. Hsu, H.J. Lin, M.D. Yang, Y.L. Chen, M.J. Fan, J.S. Yang, P.Y. Cheng, C.L. Kuo, J.G. Chung, Curcumin induces apoptosis through FAS and FADD, in caspase-3-dependent and -independent pathways in the N18 mouse-rat hybrid retina ganglion cells. Oncol. Rep. 22, 97–104 (2009)
26. S. Shankar, R.K. Srivastava, Bax and Bak genes are essential for maximum apoptotic response by curcumin, a polyphenolic compound and cancer chemopreventive agent derived from turmeric, Curcuma longa. Carcinog. 28, 1277–1286 (2007)
27. M. Roy, S. Chakraborty, M. Siddiqi, R.K. Bhattacharya, Induction of Apoptosis in Tumor Cells by Natural Phenolic Compounds. Asian Pac. J. Cancer Prev. 3, 61–67 (2002)
28. K.V. Dinesh Babu, K.N. Rajasekaran, Simplified conditions for the synthesis of curcumin I and other curcuminoids. Org. Prep. Proc. Int. 24, 674–677 (1994)
29. R.J. Fido, A.S. Tatham, P.R. Shewry, Western blotting analysis, in Methods in molecular biology: plant gene transfer and expression protocols, ed. by H. Jones, vol. 49 (Humana Press Inc, Totowa, 1995), pp. 423–437
30. P. Chomczynski, N. Sacchi, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156–159 (1987)
31. C. Brana, C. Benham, L. Sundstrom, A method for characterising cell death in vitro by combining propidium iodide staining with immunohistochemistry. Brain Res. Brain Res. Protoc. 10, 109–114 (2002)
32. R.A. Friesner, R.B. Murphy, M.P. Repasky, L.L. Frye, J.R. Greenwood, T.A. Halgren, P.C. Sanschagrin, D.T. Mainz, Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J. Med. Chem. 4, 6177–6196 (2006)
33. D. Hanahan, R.A. Weinberg, Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011)
34. C. Ramachandran, S. Rodriguez, R. Ramachandran, P.K. Raveendran Nair, H. Fonseca, Z. Khatib, E. Escalon, S.J. Melnick, Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines. Anticancer Res. 25, 3293–3302 (2005)
35. S.W. Lowe, E. Cepero, G. Evan, Intrinsic tumour suppression. Nature 432, 307–315 (2004)
36. T. Miyashita, J.C. Reed, Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293–299 (1995)
37. S. Awantika, K. Durga Prasad, G. Archana, In Silico molecular docking analysis to identify PI3K inhibitors as possible NSCLC agents. Int. J. Comput. Bioinfo. In Silico Model 2, 68–71 (2013)
38. U.M. Moll, O. Petrenko, The MDM2-p53 interaction. Mol. Cancer Res. 1, 1001–1008 (2003)
39. R. Wilken, M.S. Veena, M.B. Wang, E.S. Srivatsan, Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol. Cancer 10, 12 (2011)
40. S. Shankar, Q. Chen, K. Sarva, I. Siddiqui, R.K. Srivastava, Curcumin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells: molecular mechanisms of apoptosis, migration and angiogenesis. J. Mol. Signal. 2, 10 (2007)
41. R.U. Janicke, M.L. Sprengart, M.R. Wati, A.G. Porter, Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 273, 9357–9360 (1998)
42. H.Y. Chang, X. Yang, Proteases for cell suicide: functions and regulation of caspases. Microbiol. Mol. Biol. Rev. 64, 821–846 (2000)
43. R. Prasanna, C.C. Harish, R. Pichai, D. Sakthisekaran, P. Gunasekaran, Anti-cancer effect of Cassia auriculata leaf extract in vitro through cell cycle arrest and induction of apoptosis in human breast and larynx cancer cell lines. Cell Biol. Int. 33, 127–134 (2009)
44. C.B. Gonzales, N.B. Kirma, J.J. De La Chapa, R. Chen, M.A. Henry, S. Luo, K.M. Hargreaves, Vanilloids induce oral cancer apoptosis independent of TRPV1. Oral Oncol. 50, 437–447 (2014)
45. D. Wang, J. Hu, L. Lv, X. Xia, J. Liu, X. Li, Enhanced inhibitory effect of curcumin via reactive oxygen species generation in human nasopharyngeal carcinoma cells following purple-light irradiation. Oncol. Lett. 6, 81–85 (2013)
46. A. Shehzad, J. Lee, T.L. Huh, Y.S. Lee, Curcumin induces apoptosis in human colorectal carcinoma (HCT-15) cells by regulating expression of Prp4 and p53. Mol. Cells 35, 526–532 (2013)
47. T. Atsumi, K. Tonosaki, S. Fujisawa, Induction of early apoptosis and ROS-generation activity in human gingival fibroblasts (HGF) and human submandibular gland carcinoma (HSG) cells treated with curcumin. Arch. Oral Biol. 51, 913–921 (2006)
48. N. Hasima, B.B. Aggarwal, Cancer-linked targets modulated by curcumin. Int. J. Biochem. Mol. Biol. 3, 328–351 (2012)
49. S. Shishodia, Molecular mechanisms of curcumin action: gene expression. Biofactors 39, 37–55 (2013)
50. G.P. Maiti, P. Mondal, N. Mukherjee, A. Ghosh, S. Ghosh, S. Dey, J. Chakrabarty, A. Roy, J. Biswas, S. Roychoudhury, C.K. Panda, Overexpression of EGFR in head and neck squamous cell carcinoma is associated with inactivation of SH3GL2 and CDC25A genes. PLoS One 8, e63440 (2013)
51. J. Stamos, M.X. Sliwkowski, C. Eigenbrot, Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J. Biol. Chem. 277, 46265–46272 (2002)
52. R.B. Cohen, Current challenges and clinical investigations of epidermal growth factor receptor (EGFR) - and ErbB family-targeted agents in the treatment of head and neck squamous cell carcinoma (HNSCC). Cancer Treat. Rev. 40, 567–577 (2014)
53. M.E. Noble, J.A. Endicott, L.N. Johnson, Protein kinase inhibitors: insights into drug design from structure. Science 303, 1800–1805 (2004)
54. J.J. Liao, Molecular recognition of protein kinase binding pockets for design of potent and selective kinase inhibitors. J. Med. Chem. 50, 409–424 (2007)
55. Y.H. Peng, H.Y. Shiao, C.H. Tu, P.M. Liu, J.T. Hsu, P.K. Amancha, J.S. Wu, M.S. Coumar, C.H. Chen, S.Y. Wang, W.H. Lin, H.Y. Sun, Y.S. Chao, P.C. Lyu, H.P. Hsieh, S.Y. Wu, Protein kinase inhibitor design by targeting the Asp-Phe-Gly (DFG) motif: the role of the DFG motif in the design of epidermal growth factor receptor inhibitors. J. Med. Chem. 56, 3889–3903 (2013)